TOPAMAX
Dead / Cancelled — Cancelled — Section 8 (as of 17 Feb 2012)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78278329
- Registration number
- 2968496
- Mark type
- Word mark
- Filed
- 24 Jul 2003
- Published for opposition
- 13 Apr 2004
- Registered
- 12 Jul 2005
- Attorney of record
- Michael J. Ryan, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Prescription drug for treatment of migraines
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prior registrations
Prosecution history
- 17 Feb 2012 — CANCELLED SEC. 8 (6-YR)
- 12 Jul 2005 — REGISTERED-PRINCIPAL REGISTER
- 22 Apr 2005 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 22 Apr 2005 — ASSIGNED TO LIE
- 15 Apr 2005 — ASSIGNED TO LIE
- 13 Apr 2005 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Apr 2005 — ASSIGNED TO EXAMINER
- 09 Apr 2005 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Feb 2005 — USE AMENDMENT FILED
- 16 Feb 2005 — PAPER RECEIVED
- 25 Jan 2005 — SOU EXTENSION 1 GRANTED
- 05 Jan 2005 — SOU EXTENSION 1 FILED
- 05 Jan 2005 — SOU TEAS EXTENSION RECEIVED
- 06 Jul 2004 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 13 Apr 2004 — PUBLISHED FOR OPPOSITION